The DOI matches its Crossref record.
It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS
Open accessAbstract
It can be argued that the last true paradigm shift in the bioanalytical (BA) arena was the shift from high‐performance liquid chromatography (HPLC) with ultraviolet (UV) detection to HPLC with tandem mass spectrometry (MS/MS) detection after the commercialization of the triple quadrupole mass spectrometer in the 1990s. HPLC‐MS/MS analysis based on selected reaction monitoring (SRM) has become the gold standard for BA assays and is used by all the major pharmaceutical companies for the quantitative analysis of new drug entities (NCEs) as part of the new drug discovery and development process. While LC‐MS/MS continues to be the best tool for drug discovery bioanalysis, a new paradigm involving high‐resolution mass spectrometry (HRMS) and ultrahigh‐pressure liquid chromatography (uHPLC) is starting to make inroads into the pharmaceutical industry. The ability to collect full scan spectra, with excellent mass accuracy, mass resolution, 10–250 ms scan speeds and no NCE‐related MS parameter optimization, makes the uHPLC‐HRMS techniques suitable for quantitative analysis of NCEs while preserving maximum qualitative information about other drug‐related and endogenous components such as metabolites, degradants, biomarkers and formulation materials. In this perspective article, we provide some insight into the evolution of the hybrid quadrupole‐time‐of‐flight (Qq‐TOF) mass spectrometer and propose some of the desirable specifications that such HRMS systems should have to be integrated into the drug discovery bioanalytical workflow for performing integrated qualitative and quantitative bioanalysis of drugs and related components. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The use of mass spectrometry to analyze dried blood spots
Wagner, M., Tonoli, D., Varesio, E., & Hopfgartner, G. (2016) · Mass Spectrometry Reviews · doi:10.1002/mas.21441 · Cited by 262
Hines, J. M., Bancos, I., Bancos, C., Singh, R. D., Avula, A. V., Young, W. F., Grebe, S. K., & Singh, R. J. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.271106 · Cited by 111
Metadata
- Authors
- Ramanathan, R., Jemal, M., Ramagiri, S., Xia, Y., Humpreys, W. G., Olah, T., & Korfmacher, W. A.
- Venue
- Journal of Mass Spectrometry
- Publisher
- Wiley
- Published
- 2011-06
- Volume
- 46
- Issue
- 6
- Pages
- 595-601
- ISSN
- 1076-5174 (ISSN-L)
- 1096-9888
- OpenAlex
- W1977839424
- Cited by
- 186
- References
- 0
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. https://app.cochat.ai/papers/10.1002/jms.1921
- The paper
- Ramanathan, R., Jemal, M., Ramagiri, S., Xia, Y., Humpreys, W. G., Olah, T., & Korfmacher, W. A. (2011). It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.1921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.